EMERALD MUTUAL FUND ADVISERS TRUST

Mutual Fund

Position in SYRE — Spyre Therapeutics, Inc.

CIK 1352895 Leola, PA

Position in SYRE

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$35,624,839

+$15,039,620 QoQ

Shares Held

401,271

-1.7% QoQ

Ownership

0.455%

of shares outstanding

% of Portfolio

1.29%

of 13F equity value

Holder Rank

#43

of 265 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

EMERALD MUTUAL FUND ADVISERS TRUST holds $391,799,835 across 21 Biotechnology names. SYRE ranks #4 (9.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	1,032,024	$58,629,283
2	CORT	Corcept Therapeutics Inc	464,902	$40,423,228
3	COGT	Cogent Biosciences, Inc.	1,031,378	$39,914,328
4	SYRE	Spyre Therapeutics, Inc. This page	401,271	$35,624,839
5	MIRM	Mirum Pharmaceuticals, Inc.	289,372	$33,876,780
6	MANE	Veradermics, Inc	209,924	$25,808,056
7	CYTK	Cytokinetics Inc	279,769	$23,833,521
8	TRVI	Trevi Therapeutics, Inc.	1,210,965	$22,584,497

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,624,839	401,271	-1.7%	Shares	Sole	2026-08-05
2026-03-31	$20,585,219	408,113	-1.0%	Shares	Sole	2026-05-04
2025-12-31	$13,509,273	412,371	+33.8%	Shares	Sole	2026-02-09
2025-09-30	$5,165,633	308,212	-6.4%	Shares	Sole	2025-10-30
2025-06-30	$4,931,567	329,430	-15.4%	Shares	Sole	2025-08-04
2025-03-31	$6,283,323	389,422	+0.8%	Shares	Sole	2025-05-01
2024-12-31	$8,995,019	386,384	+52.4%	Shares	Sole	2025-02-14
2024-09-30	$7,456,905	253,550	—	Shares	Sole	2024-10-29
No filing history on record for this holder in this stock.